Prescription drug · ANDA
Levalbuterol NDC 65862-942
Levalbuterol hydrochloride 1.25 mg/.5mL · Solution, Concentrate · Respiratory (Inhalation) · Aurobindo Pharma Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65862-942-03 | 65862094203 | 30 POUCH in 1 CARTON (65862-942-03) / 1 VIAL, SINGLE-DOSE in 1 POUCH (65862-942-50) / .5 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 31, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Levalbuterol
- Generic name (nonproprietary)
- levalbuterol
- Active ingredients
- Levalbuterol hydrochloride — 1.25 mg/.5mL
- Dosage form
- Solution, Concentrate
- Route
- Respiratory (Inhalation)
- Labeler
- Aurobindo Pharma LimitedNDC labeler code 65862
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207628
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta2-Agonists (Mechanism)
- Identifiers
- Product ID 65862-942_08fe55b3-a3cd-d8cf-e063-6394a90a1a95SPL ID 08fe55b3-a3cd-d8cf-e063-6394a90a1a95SPL set ID e1a9effb-6ef7-4651-b0ef-a9265600caffRxCUI 1855389UNII WDQ1526QJM
- Pharmacologic class
- beta2-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N465862094203followed by a unit qualifier and the quantityPackage 65862-0942-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Levalbuterol inhalation solution (concentrate) is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. Levalbuterol inhalation solution (concentrate) is a beta 2 -adrenergic agonist indicated for: Treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. (1)
Excerpt only. Read the full label for complete information.
About NDC 65862-942
- What is NDC 65862-942?
- 65862-942 is the product NDC for Levalbuterol, Levalbuterol hydrochloride 1.25 mg/.5mL solution, concentrate, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Levalbuterol.
- What is the active ingredient?
- Levalbuterol hydrochloride.
- Who is the labeler?
- Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Levalbuterol?
- 29 other product NDCs are listed under this name. See all Levalbuterol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Levalbuterol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Levalbuterollevalbuterol hydrochloride | Levalbuterol hydrochloride .31 mg/3mL | SolutionRespiratory (Inhalation) | Burel Pharmaceuticals, LLC | 35573-443 | 35573-0443-25 |
| Levalbuterollevalbuterol hydrochloride | Levalbuterol hydrochloride .63 mg/3mL | SolutionRespiratory (Inhalation) | Burel Pharmaceuticals, LLC | 35573-444 | 35573-0444-25 |
| Levalbuterollevalbuterol hydrochloride | Levalbuterol hydrochloride 1.25 mg/3mL | SolutionRespiratory (Inhalation) | Burel Pharmaceuticals, LLC | 35573-445 | 35573-0445-25 |
| Levalbuterollevalbuterol hydrochloride | Levalbuterol hydrochloride .63 mg/3mL | SolutionRespiratory (Inhalation) | A-S Medication Solutions | 50090-6377 | 50090-6377-00 |
| Levalbuterollevalbuterol hydrochloride | Levalbuterol hydrochloride .63 mg/3mL | SolutionRespiratory (Inhalation) | Redpharm Drug | 67296-2304 | 67296-2304-02 |
| Levalbuterol | Levalbuterol hydrochloride 1.25 mg/3mL | SolutionRespiratory (Inhalation) | Mylan Pharmaceuticals Inc. | 0378-9692 | 00378-9692-52 |
| Levalbuterol | Levalbuterol hydrochloride .31 mg/3mL | SolutionRespiratory (Inhalation) | Mylan Pharmaceuticals Inc. | 0378-9690 | 00378-9690-52 |
| Levalbuterol | Levalbuterol hydrochloride .63 mg/3mL | SolutionRespiratory (Inhalation) | Mylan Pharmaceuticals Inc. | 0378-9691 | 00378-9691-52 |
| Levalbuterol | Levalbuterol hydrochloride .31 mg/3mL | SolutionRespiratory (Inhalation) | Aurobindo Pharma Limited | 65862-943 | 65862-0943-25 |
| Levalbuterol | Levalbuterol hydrochloride .63 mg/3mL | SolutionRespiratory (Inhalation) | Aurobindo Pharma Limited | 65862-944 | 65862-0944-25 |